Elevance Health Revenue 2012-2026 | ELV
Elevance Health annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Elevance Health revenue for the quarter ending March 31, 2026 was $50.181B, a 2.64% increase year-over-year.
- Elevance Health revenue for the twelve months ending March 31, 2026 was $200.415B, a 9.32% increase year-over-year.
- Elevance Health annual revenue for 2025 was $199.125B, a 12.49% increase from 2024.
- Elevance Health annual revenue for 2024 was $177.011B, a 3.31% increase from 2023.
- Elevance Health annual revenue for 2023 was $171.34B, a 9.42% increase from 2022.
|
Elevance Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $199,125 |
| 2024 | $177,011 |
| 2023 | $171,340 |
| 2022 | $156,595 |
| 2021 | $138,639 |
| 2020 | $121,867 |
| 2019 | $104,213 |
| 2018 | $92,105 |
| 2017 | $90,040 |
| 2016 | $84,863 |
| 2015 | $79,157 |
| 2014 | $73,874 |
| 2013 | $71,024 |
| 2012 | $61,497 |
| 2011 | $60,711 |
|
Elevance Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-03-31 | $50,181 |
| 2025-12-31 | $49,747 |
| 2025-09-30 | $50,711 |
| 2025-06-30 | $49,776 |
| 2025-03-31 | $48,891 |
| 2024-12-31 | $45,442 |
| 2024-09-30 | $45,106 |
| 2024-06-30 | $43,886 |
| 2024-03-31 | $42,577 |
| 2023-12-31 | $42,647 |
| 2023-09-30 | $42,849 |
| 2023-06-30 | $43,672 |
| 2023-03-31 | $42,172 |
| 2022-12-31 | $39,929 |
| 2022-09-30 | $39,939 |
| 2022-06-30 | $38,632 |
| 2022-03-31 | $38,095 |
| 2021-12-31 | $36,581 |
| 2021-09-30 | $35,822 |
| 2021-06-30 | $33,851 |
| 2021-03-31 | $32,385 |
| 2020-12-31 | $31,824 |
| 2020-09-30 | $31,158 |
| 2020-06-30 | $29,264 |
| 2020-03-31 | $29,621 |
| 2019-12-31 | $27,407 |
| 2019-09-30 | $26,674 |
| 2019-06-30 | $25,466 |
| 2019-03-31 | $24,666 |
| 2018-12-31 | $23,373 |
| 2018-09-30 | $23,251 |
| 2018-06-30 | $22,944 |
| 2018-03-31 | $22,537 |
| 2017-12-31 | $22,681 |
| 2017-09-30 | $22,426 |
| 2017-06-30 | $22,407 |
| 2017-03-31 | $22,526 |
| 2016-12-31 | $21,714 |
| 2016-09-30 | $21,404 |
| 2016-06-30 | $21,456 |
| 2016-03-31 | $20,289 |
| 2015-12-31 | $20,188 |
| 2015-09-30 | $19,902 |
| 2015-06-30 | $20,016 |
| 2015-03-31 | $19,052 |
| 2014-12-31 | $18,984 |
| 2014-09-30 | $18,557 |
| 2014-06-30 | $18,473 |
| 2014-03-31 | $17,859 |
| 2013-12-31 | $17,902 |
| 2013-09-30 | $17,856 |
| 2013-06-30 | $17,690 |
| 2013-03-31 | $17,576 |
| 2012-12-31 | $15,322 |
| 2012-09-30 | $15,353 |
| 2012-06-30 | $15,407 |
| 2012-03-31 | $15,415 |
| 2011-12-31 | $15,318 |
| 2011-09-30 | $15,398 |
| 2011-06-30 | $15,101 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $68.432B | $199.125B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |